Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2026-06-11 Sale | 2026-06-11 4:37 pm | KalVista Pharmaceuticals Inc. | KALV | Audhya Paul K. CHIEF MEDICAL OFFICER | 150,260 | $0 | $0 | 0 (Direct) | View |
| 2026-06-11 Sale | 2026-06-11 4:32 pm | KalVista Pharmaceuticals Inc. | KALV | Sweeny Nicole Chief Commercial Officer | 59,291 | $0 | $0 | 0 (Direct) | View |
| 2026-06-11 Sale | 2026-06-11 4:27 pm | KalVista Pharmaceuticals Inc. | KALV | Palleiko Benjamin L CHIEF EXECUTIVE OFFICER | 479,989 | $0 | $0 | 0 (Direct) | View |
| 2026-06-11 Sale | 2026-06-11 4:26 pm | KalVista Pharmaceuticals Inc. | KALV | Yea Christopher CHIEF DEVELOPMENT OFFICER | 229,918 | $0 | $0 | 0 (Direct) | View |
| 2026-06-11 Sale | 2026-06-11 4:25 pm | KalVista Pharmaceuticals Inc. | KALV | Piekos Brian Chief Financial Officer | 21,661 | $0 | $0 | 0 (Direct) | View |
| 2026-05-27 Sale | 2026-05-29 4:05 pm | KalVista Pharmaceuticals Inc. | KALV | Yea Christopher CHIEF DEVELOPMENT OFFICER | 33,800 | $26.78 | $905,225 | 229,918 (Direct) | View |
| 2026-05-26 Sale | 2026-05-27 4:05 pm | KalVista Pharmaceuticals Inc. | KALV | Yea Christopher CHIEF DEVELOPMENT OFFICER | 1,966 | $26.78 | $52,645 | 254,918 (Direct) | View |
| 2026-05-26 Sale | 2026-05-27 4:05 pm | KalVista Pharmaceuticals Inc. | KALV | Sweeny Nicole Chief Commercial Officer | 1,489 | $26.78 | $39,872 | 99,291 (Direct) | View |
| 2026-05-26 Sale | 2026-05-27 4:05 pm | KalVista Pharmaceuticals Inc. | KALV | Audhya Paul K. CHIEF MEDICAL OFFICER | 2,239 | $26.78 | $59,955 | 190,260 (Direct) | View |
| 2026-05-22 Sale | 2026-05-26 7:35 pm | KalVista Pharmaceuticals Inc. | KALV | Palleiko Benjamin L CHIEF EXECUTIVE OFFICER | 10,926 | $26.78 | $292,646 | 735,739 (Direct) | View |
| 2026-05-22 Sale | 2026-05-26 7:34 pm | KalVista Pharmaceuticals Inc. | KALV | Sweeny Nicole Chief Commercial Officer | 1,861 | $26.78 | $49,846 | 124,530 (Direct) | View |
| 2026-05-22 Sale | 2026-05-26 7:33 pm | KalVista Pharmaceuticals Inc. | KALV | Yea Christopher CHIEF DEVELOPMENT OFFICER | 2,358 | $26.78 | $63,158 | 270,009 (Direct) | View |
| 2026-05-22 Sale | 2026-05-26 7:33 pm | KalVista Pharmaceuticals Inc. | KALV | Audhya Paul K. CHIEF MEDICAL OFFICER | 2,685 | $26.78 | $71,916 | 216,249 (Direct) | View |
| 2026-05-22 Sale | 2026-05-26 7:32 pm | KalVista Pharmaceuticals Inc. | KALV | Piekos Brian Chief Financial Officer | 1,489 | $26.78 | $39,882 | 76,661 (Direct) | View |
| 2026-05-18 Sale | 2026-05-19 4:05 pm | KalVista Pharmaceuticals Inc. | KALV | Yea Christopher CHIEF DEVELOPMENT OFFICER | 1,108 | $26.76 | $29,650 | 227,367 (Direct) | View |
| 2026-05-18 Sale | 2026-05-19 4:04 pm | KalVista Pharmaceuticals Inc. | KALV | Audhya Paul K. CHIEF MEDICAL OFFICER | 1,032 | $26.76 | $27,616 | 143,934 (Direct) | View |
| 2026-05-18 Sale | 2026-05-19 4:03 pm | KalVista Pharmaceuticals Inc. | KALV | Palleiko Benjamin L CHIEF EXECUTIVE OFFICER | 1,129 | $26.76 | $30,212 | 467,665 (Direct) | View |
| 2026-05-12 Sale | 2026-05-13 4:25 pm | KalVista Pharmaceuticals Inc. | KALV | Palleiko Benjamin L CHIEF EXECUTIVE OFFICER | 3,322 | $26.71 | $88,731 | 558,935 (Direct) | View |
| 2026-04-17 Sale | 2026-04-20 7:42 pm | KalVista Pharmaceuticals Inc. | KALV | Audhya Paul K. CHIEF MEDICAL OFFICER | 2,686 | $20.22 | $54,301 | 236,297 (Direct) | View |
| 2026-04-17 Sale | 2026-04-20 7:41 pm | KalVista Pharmaceuticals Inc. | KALV | Sweeny Nicole Chief Commercial Officer | 1,862 | $20.22 | $37,643 | 145,141 (Direct) | View |
| 2026-04-17 Sale | 2026-04-20 7:40 pm | KalVista Pharmaceuticals Inc. | KALV | Piekos Brian Chief Financial Officer | 1,862 | $20.22 | $37,643 | 111,900 (Direct) | View |
| 2026-04-17 Sale | 2026-04-20 7:40 pm | KalVista Pharmaceuticals Inc. | KALV | Palleiko Benjamin L CHIEF EXECUTIVE OFFICER | 9,550 | $20.22 | $193,066 | 767,265 (Direct) | View |
| 2026-03-25 Sale | 2026-03-27 5:50 pm | KalVista Pharmaceuticals Inc. | KALV | Venrock Healthcare Capital Partners III L.P. VHCP Co-Investment Holdings III LLC VHCP Management EG LLC Venrock Healthcare Capital Partners EG L.P. VHCP Management III LLC Koh Bong Y Shah Nimish P 10% Owner | 214,631 | $17.2 | $3,691,148 | 5,089,354 (Indirect) | View |
| 2026-03-09 Sale | 2026-03-10 6:47 pm | KalVista Pharmaceuticals Inc. | KALV | Palleiko Benjamin L CHIEF EXECUTIVE OFFICER | 6,693 | $16.08 | $107,633 | 576,816 (Direct) | View |
| 2026-02-23 Sale | 2026-02-24 7:44 pm | KalVista Pharmaceuticals Inc. | KALV | Audhya Paul K. CHIEF MEDICAL OFFICER | 5,354 | $15.57 | $83,345 | 258,983 (Direct) | View |
| 2026-02-23 Sale | 2026-02-24 7:44 pm | KalVista Pharmaceuticals Inc. | KALV | Palleiko Benjamin L CHIEF EXECUTIVE OFFICER | 10,034 | $15.57 | $156,197 | 721,883 (Direct) | View |
| 2026-02-23 Sale | 2026-02-24 7:43 pm | KalVista Pharmaceuticals Inc. | KALV | Yea Christopher CHIEF DEVELOPMENT OFFICER | 4,347 | $15.57 | $67,669 | 299,826 (Direct) | View |
| 2026-02-23 Sale | 2026-02-24 7:42 pm | KalVista Pharmaceuticals Inc. | KALV | Sweeny Nicole Chief Commercial Officer | 3,975 | $15.57 | $61,878 | 167,003 (Direct) | View |
| 2026-02-23 Sale | 2026-02-24 7:42 pm | KalVista Pharmaceuticals Inc. | KALV | Piekos Brian Chief Financial Officer | 1,767 | $15.57 | $27,507 | 73,762 (Direct) | View |
| 2026-02-18 Sale | 2026-02-19 7:45 pm | KalVista Pharmaceuticals Inc. | KALV | Palleiko Benjamin L CHIEF EXECUTIVE OFFICER | 1,038 | $15 | $15,570 | 432,086 (Direct) | View |
| 2026-02-18 Sale | 2026-02-19 7:44 pm | KalVista Pharmaceuticals Inc. | KALV | Audhya Paul K. CHIEF MEDICAL OFFICER | 1,163 | $15 | $17,445 | 135,506 (Direct) | View |
| 2026-02-18 Sale | 2026-02-19 7:44 pm | KalVista Pharmaceuticals Inc. | KALV | Yea Christopher CHIEF DEVELOPMENT OFFICER | 1,109 | $15 | $16,635 | 225,947 (Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2026-05-27 Exercise | 2026-05-29 4:05 pm | N/A 2027-05-24 | KalVista Pharmaceuticals Inc. | KALV | Yea Christopher CHIEF DEVELOPMENT OFFICER | 33,800 | $0 | 229,918 (Direct) | View |
| 2026-05-27 Exercise | 2026-05-29 4:05 pm | N/A N/A | KalVista Pharmaceuticals Inc. | KALV | Yea Christopher CHIEF DEVELOPMENT OFFICER | 33,800 | $7.07 | 229,918 (Direct) | View |
| 2026-05-22 Exercise | 2026-05-27 4:05 pm | N/A N/A | KalVista Pharmaceuticals Inc. | KALV | Yea Christopher CHIEF DEVELOPMENT OFFICER | 3,125 | $0 | 254,918 (Direct) | View |
| 2026-05-22 Exercise | 2026-05-27 4:05 pm | N/A N/A | KalVista Pharmaceuticals Inc. | KALV | Sweeny Nicole Chief Commercial Officer | 5,000 | $0 | 99,291 (Direct) | View |
| 2026-05-22 Exercise | 2026-05-27 4:05 pm | N/A N/A | KalVista Pharmaceuticals Inc. | KALV | Audhya Paul K. CHIEF MEDICAL OFFICER | 5,000 | $0 | 190,260 (Direct) | View |
| 2026-05-21 Exercise | 2026-05-26 7:35 pm | N/A N/A | KalVista Pharmaceuticals Inc. | KALV | Palleiko Benjamin L CHIEF EXECUTIVE OFFICER | 23,250 | $0 | 735,739 (Direct) | View |
| 2026-05-21 Exercise | 2026-05-26 7:34 pm | N/A N/A | KalVista Pharmaceuticals Inc. | KALV | Sweeny Nicole Chief Commercial Officer | 6,250 | $0 | 124,530 (Direct) | View |
| 2026-05-21 Exercise | 2026-05-26 7:33 pm | N/A N/A | KalVista Pharmaceuticals Inc. | KALV | Yea Christopher CHIEF DEVELOPMENT OFFICER | 3,750 | $0 | 270,009 (Direct) | View |
| 2026-05-21 Exercise | 2026-05-26 7:33 pm | N/A N/A | KalVista Pharmaceuticals Inc. | KALV | Audhya Paul K. CHIEF MEDICAL OFFICER | 6,250 | $0 | 216,249 (Direct) | View |
| 2026-05-21 Exercise | 2026-05-26 7:32 pm | N/A N/A | KalVista Pharmaceuticals Inc. | KALV | Piekos Brian Chief Financial Officer | 5,000 | $0 | 76,661 (Direct) | View |
| 2026-05-17 Exercise | 2026-05-19 4:05 pm | N/A N/A | KalVista Pharmaceuticals Inc. | KALV | Yea Christopher CHIEF DEVELOPMENT OFFICER | 1,774 | $0 | 227,367 (Direct) | View |
| 2026-05-17 Exercise | 2026-05-19 4:04 pm | N/A N/A | KalVista Pharmaceuticals Inc. | KALV | Audhya Paul K. CHIEF MEDICAL OFFICER | 2,419 | $0 | 143,934 (Direct) | View |
| 2026-05-17 Exercise | 2026-05-19 4:03 pm | N/A N/A | KalVista Pharmaceuticals Inc. | KALV | Palleiko Benjamin L CHIEF EXECUTIVE OFFICER | 2,419 | $0 | 467,665 (Direct) | View |
| 2026-05-11 Exercise | 2026-05-13 4:25 pm | N/A N/A | KalVista Pharmaceuticals Inc. | KALV | Palleiko Benjamin L CHIEF EXECUTIVE OFFICER | 7,120 | $0 | 558,935 (Direct) | View |
| 2026-04-16 Exercise | 2026-04-20 7:42 pm | N/A N/A | KalVista Pharmaceuticals Inc. | KALV | Audhya Paul K. CHIEF MEDICAL OFFICER | 6,250 | $0 | 236,297 (Direct) | View |
| 2026-04-16 Exercise | 2026-04-20 7:41 pm | N/A N/A | KalVista Pharmaceuticals Inc. | KALV | Sweeny Nicole Chief Commercial Officer | 6,250 | $0 | 145,141 (Direct) | View |
| 2026-04-16 Exercise | 2026-04-20 7:40 pm | N/A N/A | KalVista Pharmaceuticals Inc. | KALV | Piekos Brian Chief Financial Officer | 6,250 | $0 | 111,900 (Direct) | View |
| 2026-04-16 Exercise | 2026-04-20 7:40 pm | N/A N/A | KalVista Pharmaceuticals Inc. | KALV | Palleiko Benjamin L CHIEF EXECUTIVE OFFICER | 20,312 | $0 | 767,265 (Direct) | View |
| 2026-03-06 Exercise | 2026-03-10 6:47 pm | N/A N/A | KalVista Pharmaceuticals Inc. | KALV | Palleiko Benjamin L CHIEF EXECUTIVE OFFICER | 15,625 | $0 | 576,816 (Direct) | View |
| 2026-02-21 Exercise | 2026-02-24 7:44 pm | N/A N/A | KalVista Pharmaceuticals Inc. | KALV | Audhya Paul K. CHIEF MEDICAL OFFICER | 11,250 | $0 | 258,983 (Direct) | View |
| 2026-02-21 Exercise | 2026-02-24 7:44 pm | N/A N/A | KalVista Pharmaceuticals Inc. | KALV | Palleiko Benjamin L CHIEF EXECUTIVE OFFICER | 23,250 | $0 | 721,883 (Direct) | View |
| 2026-02-21 Exercise | 2026-02-24 7:43 pm | N/A N/A | KalVista Pharmaceuticals Inc. | KALV | Yea Christopher CHIEF DEVELOPMENT OFFICER | 6,875 | $0 | 299,826 (Direct) | View |
| 2026-02-21 Exercise | 2026-02-24 7:42 pm | N/A N/A | KalVista Pharmaceuticals Inc. | KALV | Sweeny Nicole Chief Commercial Officer | 11,250 | $0 | 167,003 (Direct) | View |
| 2026-02-21 Exercise | 2026-02-24 7:42 pm | N/A N/A | KalVista Pharmaceuticals Inc. | KALV | Piekos Brian Chief Financial Officer | 5,000 | $0 | 73,762 (Direct) | View |
| 2026-02-17 Exercise | 2026-02-19 7:45 pm | N/A N/A | KalVista Pharmaceuticals Inc. | KALV | Palleiko Benjamin L CHIEF EXECUTIVE OFFICER | 2,419 | $0 | 432,086 (Direct) | View |
| 2026-02-17 Exercise | 2026-02-19 7:44 pm | N/A N/A | KalVista Pharmaceuticals Inc. | KALV | Audhya Paul K. CHIEF MEDICAL OFFICER | 2,419 | $0 | 135,506 (Direct) | View |
| 2026-02-17 Exercise | 2026-02-19 7:44 pm | N/A N/A | KalVista Pharmaceuticals Inc. | KALV | Yea Christopher CHIEF DEVELOPMENT OFFICER | 1,774 | $0 | 225,947 (Direct) | View |